#Deep Brain Stimulation (DBS) Devices Market Trends

[wellnessweb]

Deep Brain Stimulation Devices Market Size: Current Trends and Future Outlook

The Deep Brain Stimulation Devices Market size was estimated at USD 1.30 billion in 2023 and is expected to reach USD 2.76 billion By 2031 at a CAGR of 9.8% during the forecast period of 2024-2031.The Deep Brain Stimulation (DBS) Devices Market is experiencing significant growth, driven by advancements in neuromodulation technology and an increasing prevalence of neurological disorders such as Parkinson's disease, dystonia, and essential tremor. This market is characterized by a surge in demand for minimally invasive surgical treatments that offer substantial improvements in patient quality of life. Innovations in DBS device design, including enhanced battery life, reduced device size, and improved precision in targeting brain regions, are further propelling market expansion. Additionally, the rising geriatric population, along with greater healthcare expenditure and supportive government policies, is fueling the adoption of DBS devices. Major players in the industry are focusing on strategic collaborations and extensive R&D to develop next-generation DBS systems that integrate advanced features such as remote programming and adaptive stimulation, ensuring a robust market growth trajectory in the coming years.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/3335

Market Scope & Overview

The market research report is an ideal source of information, and market studies are crucial for global businesses. In order to give a qualitative and quantitative evaluation of the development of the global economy, Deep Brain Stimulation Devices Market research examines a wide range of nations. The market research study analyses historical information and forecasts to estimate the size of the global market. The global business overview includes tables and figures with key industry statistics, market data and analysis for organizations and consumers.

The primary and secondary methodologies, well-known research techniques, and services are all examined in the Deep Brain Stimulation Devices Market research study. In a market study, the principal market characteristics and prospects, as well as its boundaries and key rivals, corporate profiles, and general positioning strategy for both local and international markets, are all researched.

Market Segmentation Analysis

By Product

Single Channel

Dual Channel

By Application

Pain Management

Epilepsy

Essential Tremor

Obsessive-Compulsive Disorder (OCD)

Depression

Dystonia

Parkinson’s Disease

Others

By End Use

 Hospitals

 Neurology Clinics

 Ambulatory Surgical Centres

 Research Centres

COVID-19 Pandemic Impact Analysis

The research goes into great depth about how these pandemics affected various regions of the world. The COVID-19 epidemic's global spread has had a significant influence on the Deep Brain Stimulation Devices Market in a number of ways. The report also offers advice on how market participants might continue to make money in such challenging circumstances.

Regional Outlook

The Deep Brain Stimulation Devices Market research report explains current developments in significant regional marketplaces and the various choices service providers throughout the world have. This research report covers all of Europe, North America, Latin America, Asia Pacific, and the rest of the world. A competitive market analysis ranks the top rivals based on corporate strengths and product offerings.

Competitive Analysis

The research examines the significance of the field, in addition to its many elements and anticipated repercussions. Discussions of expert perspectives, environmental facts, and marketing strategies are included. The Deep Brain Stimulation Devices Market research covers upstream sector differences, market segmentation, business environment, demand development, cost and pricing structure, and business climate.

Key Reasons to Purchase Deep Brain Stimulation Devices Market Report

The market report evaluates the findings of in-depth secondary research, primary interviews with subject matter experts, and internal expert interviews.

Financial analytics, fundamental data, regional engagement, sales effectiveness, product quality, and sector contribution are all used to rank the top businesses in the market.

Conclusion

The size of the market, the successful business practices of the major organizations, and the exposure of regional firms are some of the factors taken into account by Deep Brain Stimulation Devices Market research. For the development of market-dominating methods, these insights are crucial.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Diabetic Neuropathy Market Trends

Smart Contact Lenses Market Size Trends

Lymphoma Treatment Market Trends

Veterinary Vaccine Adjuvants Market Trends

Medical Electrodes Market Trends

[pranay-234]

Parkinson’s Disease Market: Product Development Strategies by Prominent Players and Industry Forecast 2023-2032

The field of healthcare is witnessing significant progress in the treatment and management of various medical conditions, and the Parkinson's Disease market is at the forefront of these advancements. Parkinson's Disease, a neurological disorder that affects millions globally, has become a focal point for medical research and innovation.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-toc-and-sample/10890

COVID-19 Scenario Analysis:

The COVID-19 pandemic has triggered a global response from pharmaceutical and biotechnological companies, as well as governments, on an unprecedented scale. These stakeholders have united to combat the outbreak, with a multifaceted approach encompassing vaccine development, healthcare supply chain management, and the exploration of potential drug treatments.

As of the latest data, there are approximately 115 vaccine candidates and 155 therapeutic molecules in various stages of research and development. These efforts represent a remarkable mobilization of scientific and medical resources, with the aim of not only addressing the current pandemic but also preparing for future health crises.

One notable development during the pandemic has been the surge in demand for certain existing drugs, such as hydroxychloroquine, which has been repurposed for the management of COVID-19 symptoms. This increased demand for drugs, alongside the urgency to find effective treatments, has presented a significant opportunity for manufacturers specializing in COVID-19 management drugs. Many developed countries have experienced shortages of these crucial medications, underscoring the importance of bolstering pharmaceutical supply chains and production capacities.

The heightened demand for vaccines and therapeutic drugs to combat COVID-19 is expected to lead to substantial growth in the pharmaceutical and biotechnology industry in the coming years. This growth is not only driven by the urgent need for pandemic management but also by the lessons learned and infrastructure improvements that will better prepare the healthcare industry for future challenges.

Understanding Parkinson's Disease

Parkinson's Disease is a progressive nervous system disorder that affects movement. It occurs when there is a reduction in dopamine production in the brain, leading to symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. Managing the symptoms and improving the quality of life for Parkinson's patients is the primary goal of the market.

𝐏𝐫𝐞-𝐛𝐨𝐨𝐤 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/parkinsons-disease-market/purchase-options

Key Trends Shaping the Parkinson's Disease Market:

Advanced Medications: The market has witnessed the development of advanced medications that offer more precise and effective symptom management. These drugs not only provide relief from motor symptoms but also focus on non-motor symptoms, such as mood disorders and sleep disturbances.

Deep Brain Stimulation (DBS): Surgical interventions, particularly Deep Brain Stimulation (DBS), have gained prominence. DBS is a surgical procedure that involves implanting a device to stimulate specific areas of the brain, alleviating motor symptoms and significantly enhancing the patient's quality of life.

Personalized Treatment Plans: Healthcare providers are increasingly adopting a patient-centric approach, creating personalized treatment plans based on the individual's unique needs and the stage of their disease. This approach enhances treatment effectiveness and patient satisfaction.

Telemedicine and Remote Monitoring: The COVID-19 pandemic accelerated the adoption of telemedicine in healthcare. Parkinson's patients now have greater access to remote consultations, reducing the need for in-person visits, especially for routine check-ups.

Neuroprotective Therapies: Research is ongoing in the development of neuroprotective therapies that aim to slow the progression of the disease. These therapies have the potential to change the landscape of Parkinson's Disease management.

The Future of the Parkinson's Disease Market:

The Parkinson's Disease market is poised for ongoing growth and innovation. As research and development efforts continue to focus on finding a cure and more effective treatments, patients can look forward to a brighter future with improved quality of life.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/10890

Key Takeaways:

The Parkinson's Disease market plays a pivotal role in improving the lives of patients affected by this neurological disorder.

Advanced medications, surgical interventions like DBS, and personalized treatment plans are shaping the future of Parkinson's Disease management.

Telemedicine and remote monitoring offer increased accessibility to healthcare for Parkinson's patients.

The quest for neuroprotective therapies represents hope for slowing the disease's progression.

The market's focus on patient well-being and improved treatments signifies a commitment to enhancing the quality of life for Parkinson's patients.

In conclusion, the Parkinson's Disease market is not just about managing symptoms but about providing patients with hope and better prospects for a fulfilling life. As it continues to evolve and advance, the market exemplifies the unwavering dedication of healthcare professionals to improving the lives of those affected by this complex condition.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

[astutemarketresearch]

Neurostimulation Devices Market Overview, Trends & Growth Forecast 2023 to 2031

Astute Analytica created the Global Neurostimulation Devices Market Research Report based on a thorough understanding of the client’s needs.

This research offers details on the regional and worldwide market conditions as they are right now. This offers insightful information on the world market. This industry analysis report provides specifics on market forces, market constraints, and their impact on market demand going forward. The market research provides a broad overview of this sector.

The Global Neurostimulation Devices Market was valued at US$ 8,275.6 Mn in 2022 and is estimated to reach a valuation of US$ 18,318.4 Mn by 2031, registering a CAGR of 9.7% over the forecast period 2023–2031. On the other hand, by volume, the market is projected to grow at a CAGR of 8.3% during the same period.

Download the Comprehensive PDF Strategic Report for Exclusive Details: https://www.astuteanalytica.com/request-sample/neurostimulation-device-market

The report includes data on businesses, app categories, nations, and geographies. These reports include data on trade, investments, sales, and turnover. The impact of COVID-19 on the upstream, midstream, and downstream businesses is examined via market research. This research uses statistics to analyze a number of different aspects of the industry.

The report on the worldwide Neurostimulation Devices Market looks at prospective expansion in various applications and geographical areas. The impact of industry demography and industry growth are examined in this study. The study looks at preferred channels, domain drivers, and market dynamics in emerging markets. There are also restraints in it. Prices, revenues, revenue growth, and production costs were all analyzed.

The elements in this study have the potential to significantly impact market expansion throughout the projected period. Access to the necessary data is made simple by the availability of a market dashboard with all the specifics. There are various components to the Neurostimulation Devices Market Analysis and Future Outlook. This report contains facts and information that can help businesses decide more wisely and increase their return on investment (ROI). CAGR figures are used in this study to quantify changes in or increases in product demand throughout a predicted period.

Leading Companies

Abbott Laboratories

Advanced Bionics

B. Braun Melsungen AG

Boston Scientific Corporation

BrainsWay

Cochlear

CONMED Corporation

KONINKLIJKE PHILIPS

Laborie Medical Technologies, Inc.

MED-EL Medical Electronics

Medtronic PLC

Nevro Corp

Zimmer Biomet Holdings, Inc.

Other Prominent Players

Explore the Full Comprehensive Report Here: https://www.astuteanalytica.com/industry-report/neurostimulation-device-market

Segmentation Outline

The following are the various segments of the global neurostimulation devices market:

By Device Type:

Implantable Device

Cochlear Implants (CI)

Sacral Nerve Stimulation (SNS)

Gastric Electric Stimulation (GES)

Deep Brain Stimulation (DBS)

Vagus Nerve Stimulation (VNS)

Spinal Cord Stimulation (SCS)

External Device

Transcranial Magnetic Stimulation (TMS)

Transcutaneous Electrical Nerve Stimulation (TENS)

By Application:

Pain Management

Hearing Loss

Urinary Incontinence

Parkinson’s Disease

Epilepsy

Gastroparesis

Depression

Others

By End User:

Hospitals/Clinics

Cognitive Care Centres

Research Institutes

Others

By Region:

North America

The U.S.

Canada

Mexico

Europe

Western Europe

The UK

Germany

France

Italy

Spain

Rest of Western Europe

Eastern Europe

Poland

Russia

Rest of Eastern Europe

Asia Pacific

China

India

Japan

South Korea

Australia & New Zealand

Rest of APAC

Middle East & Africa (MEA)

UAE

Saudi Arabia

South Africa

Rest of MEA

South America

Argentina

Brazil

Rest of South America

Important Developments in the Neurostimulation Devices Market:

The report examines manufacturers’ profiles, news, main companies, and revenue.

To demonstrate the intense competition that the top manufacturers in the world deal with.

Presenting the market by kind and application, along with each type’s revenue, sales, and growth rates.

An examination of the major nations in North America according to manufacturer, application, and kind. Southeast Asia and Europe. Latin America. Sales, turnover, and market shares for manufacturers.

The report examines the manufacturing expenses, raw resources, and production process.

Grab Your Sample PDF Report for Deeper Understanding: https://www.astuteanalytica.com/request-sample/neurostimulation-device-market

About Astute Analytica: Astute Analytica is a renowned global analytics and advisory company, having swiftly established a strong reputation through the tangible and impressive results delivered to our valued clients. Our commitment lies in providing unparalleled, in-depth, and remarkably accurate estimates and projections to demanding clients across diverse industries, such as technology, healthcare, chemicals, semiconductors, FMCG, and more, drawing from a wide spectrum of satisfied and returning customers from around the world.

Our clients benefit greatly from our comprehensive analysis of the complex business environment, meticulously examining existing and emerging possibilities in different segments, technological advancements, growth estimations, and strategic choices. In essence, we offer a complete package, empowering our clients to make well-informed decisions, seize highly profitable opportunities, and overcome formidable challenges.

Our strength lies in our highly qualified, competent, and experienced team of professionals, comprising proficient business analysts, economists, consultants, and technology experts. As a customer-centric organization, you, our esteemed patron, are our top priority. When you choose to engage with us, rest assured that you will receive the best cost-effective and value-added package tailored to your needs.

To connect with us, feel free to use the following contact details:

Phone number: +18884296757

Email: sales@astuteanalytica.com

Website: https://www.astuteanalytica.com/

LinkedIn | Twitter | YouTube | Facebook

[poojascmi]

Global Neuroscience Market Is Estimated To Witness High Growth Owing To Increasing Technological Advancements And Rising Prevalence of Neurological Disorders

The global Neuroscience Market is estimated to be valued at US$ 32.75 billion in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

A) Market Overview:

The field of neuroscience focuses on the study of the nervous system and how it impacts behavior and cognitive functions. The market for neuroscience products encompasses various technologies and devices used for diagnostics, therapeutic interventions, and research purposes. These products include neuroimaging systems, electrophysiology devices, neurostimulation devices, and others. The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy has driven the demand for neuroscience products.

B) Market Dynamics:

The market dynamics of the global Neuroscience Market are influenced by two key drivers:

1. Increasing technological advancements: The advancements in neuroscience technology have led to the development of sophisticated tools and techniques for studying the brain and nervous system. For example, neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) have enabled researchers to visualize brain structures and functions, aiding in the diagnosis and treatment of neurological disorders.

2. Rising prevalence of neurological disorders: The increasing prevalence of neurological disorders worldwide has created a significant demand for neuroscience products. According to the World Health Organization (WHO), approximately 1 billion people worldwide suffer from neurological disorders. This has prompted healthcare providers to adopt advanced neuroscience technologies for accurate diagnosis and effective treatment.

C) Market Key Trends:

One key trend in the Neuroscience Market is the growing adoption of neurostimulation devices for therapeutic interventions. Neurostimulation devices such as deep brain stimulation (DBS) devices and transcranial magnetic stimulation (TMS) devices have shown promising results in the management of neurological conditions. For instance, DBS devices have been proven effective in treating Parkinson's disease and essential tremors by delivering electrical impulses to specific brain areas, thus reducing symptoms.

D) SWOT Analysis:

- Strengths: Increasing technological advancements and widespread availability of neuroscience products.

- Weaknesses: High costs associated with neuroscience products and limited awareness about the benefits of these technologies.

- Opportunities: Growing demand for personalized medicine and increasing research funding in neuroscience.

- Threats: Stringent regulatory requirements and ethical concerns associated with brain research.

E) Key Takeaways:

In terms of market size, the global Neuroscience Market is expected to witness high growth, exhibiting a CAGR of 4.1% over the forecast period. This growth can be attributed to increasing technological advancements and the rising prevalence of neurological disorders.

From a regional perspective, North America is expected to dominate the market due to the presence of well-established healthcare infrastructure and a large patient population. However, the Asia-Pacific region is expected to witness the fastest growth, driven by a growing awareness about neurological disorders and increasing healthcare expenditure.

Key players operating in the global Neuroscience Market include Alpha Omega, Inc., GE Healthcare, Axion Biosystems, Inc., Siemens Healthineers, Scientifica Ltd., and others. These companies focus on collaborations, product launches, and mergers and acquisitions to strengthen their market position and expand their product portfolios.

[kritikapatil]

Brain Implants Market Unidentified Segments – The Biggest Opportunity Of 2022

Global Brain Implants Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player’s market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions. Major Players in This Report Include

Boston Scientific Corporation (United States)

St Jude Medical (United States)

Medtronic (Ireland)

Pixium Vision (France)

Neuralink (United States)

Aleva Neurotherapeutics SA (Switzerland)

Nevro Corporation (United States)

NeuroPace Inc. (United States)

NDI Medical LLC (United States)

Thermo Fisher Scientific Inc. (United States) Increased Prevalence of Neurological Disorders Like Alzheimer’s disease, The Rise in Geriatric Population and Rapid Advancements in Medical Science are the key factors driving the global brain implant market. Brain implants are the neural implants that directly connected to the brain. These implants electrically stimulate, block or record the signals from the brain. It enables communication between the brain and electronic devices, thus permitting brain activity to be modified, recorded or translated.  The purpose of these implants is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. However, the High Cost of Implant Installation may hinder the market growth. Market Drivers Increased Prevalence of Neurological Disorders Like Alzheimer’s disease

The Rise in Geriatric Population

Rapid Advancements in Medical Science

Market Trend Use of Robotic Assistance for Brain Transplant Surgery

Opportunities Increasing Healthcare Awareness and Technological Advancement

Growth in the Healthcare Sector

Increased Research and Development Activities

Challenges Brain Implants are Vulnerable to Cyber Attacks

Legal Issues and Regulations

The Brain Implants market study is being classified by Type (Deep brain stimulator (DBS), Spinal cord stimulator (SCS), Vagus nerve stimulator (VNS)), Application (Hospitals, Clinics, Healthcare Facilities, Others), Disease (Chronic Pain, Epilepsy, Parkinson’s disease, Depression, Essential tremor, Alzheimer’s disease) Presented By

AMA Research & Media LLP

[techsciresearch]

Deep Brain Stimulation Devices Market to Register Healthy Growth through 2025 – TechSci Research

Increasing patient pool suffering from Parkinson’s disease and multiple sclerosis to drive global deep brain stimulation (DBS) devices market

According to TechSci Research report, “Global Deep Brain Stimulation (DBS) Devices Market By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic, Research Centers), By Region, Forecast & Opportunities, 2025”, the market is expected to witness significant CAGR during the forecast period owing to extensive usage of these devices in the treatment of various neurological disorders such as essential tremor, Parkinson's disease, dystonia, epilepsy and obsessive compulsive disorder. Rising prevalence of lifestyle diseases including depression and chronic pain is also one of the key factors behind the growth of deep brain stimulation (DBS) devices market. Furthermore, increasing cases of neurological disorders and growing investment on R&D activities in neurological sector are some other major factors driving the growth of this market. Also, growing aging population around the world and rising demand for minimal invasive surgery are expected to propel the global deep brain stimulation (DBS) devices market through 2025.

Moreover, potential advantages of deep brain stimulation devices like improved postoperative outcome control and its long-term effectiveness are also augmenting the market growth. Adding to this, adoption of technologically advanced products is also supporting the growth of global deep brain stimulation (DBS) devices market. However, the market is also experiencing some challenges. The side effects associated with the use of deep brain stimulation devices such as allergic reaction and tingling or prickling of the skin are expected to hamper the market growth. Moreover, availability of alternative treatment options like drug therapies and surgeries might further restrict the market growth during the forecast period. The outbreak of COVID-19 has also put challenge before suppliers and consumers of deep brain stimulation (DBS) devices.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global DBS  Devices Market"

https://www.techsciresearch.com/report/deep-brain-stimulation-devices-market/5026.html

 The global deep brain stimulation (DBS) devices market is segmented based on product type, type, application, end user and region. Based on product type, the market is segmented into single-channel deep brain stimulator and dual-channel deep brain stimulator. Among them, the dual-channel deep brain stimulator accounted for largest market share in 2019 and is further expected to hold its dominance through 2025. The reasons can be attributed to their increasing use in surgical procedures for treating Parkinson's disease.

Based on application, the global deep brain stimulation (DBS) devices market is segmented into obsessive compulsive disorder, Parkinson’s disease, essential tremor, epilepsy, dystonia and others. Among them, the Obsessive-Compulsive Disorder (OCD) segment is anticipated to witness highest CAGR during the forecast period owing to increasing cases of OCD. DBS devices are more effective than other therapeutics such as serotonin reuptake inhibitors.

Major players operating in the global deep brain stimulation (DBS) devices market include Boston Scientific Corporation, Abbott Laboratories (St. Jude Medical), Beijing PINS Medical Co. Ltd, Fisher Wallace, NeuroSigma, Inc., Functional Neuromodulation Ltd, Medtronic PLC, NeuroPace Inc., Renishaw PLC, ALEVA NEUROTHERAPEUTICS SA, LivaNova PLC, SceneRay Corporation, Nevro Corporation and Neuronetics Inc. The market players are focusing on launching innovative devices and investing on latest technologies to strengthen their market position in global market.

Download Sample Report  @ https://www.techsciresearch.com/sample-report.aspx?cid=5026

Customers can also request for 10% free customization on this report.

“North America dominated the global deep brain stimulation (DBS) devices market in 2019 owing to increase in FDA approvals for these devices in clinical applications. However, Asia Pacific is expected to undergo fastest CAGR through 2025 owing to growing awareness about various neurological disease treatment options. The region is also witnessing increasing prevalence of neurodegenerative disorders, which require long term solutions,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Deep Brain Stimulation (DBS) Devices Market By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic, Research Centers), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global deep brain stimulation (DBS) devices market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global deep brain stimulation (DBS) devices market.

Browse Related Reports

Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025

 https://www.techsciresearch.com/report/self-monitoring-blood-glucose-market/4607.html

 Global Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025

 https://www.techsciresearch.com/report/portable-ventilator-market/4541.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

[healthcare-updates-with-sns]

Deep Brain Stimulation (DBS) Devices Market: Market Trends and Revenue Forecast 2024-2032

According to SNS Insider's research, “The Deep Brain Stimulation (DBS) Devices Market was valued at USD 1.57 billion in 2023 and is projected to reach USD 3.12 billion by 2031, growing at a CAGR of 9% during the forecast period 2024-2031.” This significant growth is attributed to the rising prevalence of neurological disorders, such as Parkinson's disease, epilepsy, and dystonia, coupled with increasing awareness and technological innovations in DBS devices.

Deep brain stimulation devices deliver electrical impulses to specific areas of the brain to manage symptoms of neurological conditions. The non-invasive, reversible nature of DBS therapy, combined with its proven efficacy, has made it a preferred treatment option, further fueling market expansion. Additionally, the growing elderly population prone to neurological disorders and the integration of advanced technologies like wireless remote programming and MRI compatibility are expected to boost market growth.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/3335

Regional Analysis:

North America currently dominates the DBS Devices Market, accounting for the largest share, owing to the high prevalence of Parkinson’s disease, well-established healthcare infrastructure, and rapid adoption of advanced medical technologies.

Europe follows closely, driven by increased investments in healthcare and rising awareness of neurological disease management.

Asia-Pacific is anticipated to exhibit the highest growth rate during the forecast period, propelled by improving healthcare facilities, a growing patient population, and supportive government initiatives.

Market Segmentation:

By Product:

Single-channel DBS

Dual-channel DBS

By Application:

Parkinson’s Disease

Epilepsy

Essential Tremor

Dystonia

Obsessive-Compulsive Disorder (OCD)

Others

By End-User:

Hospitals

Neurology Clinics

Ambulatory Surgical Centers

Research Centers

Key Players

The deep brain stimulation devices market players include Abbott Laboratories, Beijing Pinchi Medical Equipment Co., Ltd., Boston Scientific Corporation, Fisher Wallace Laboratories, Functional Neuromodulation Ltd., Medtronic, NeuroPace Inc., Renishaw PLC, Aleva Neurotherapeutics S.A. & LivaNova PLC & Other Players.

Key Points:

Market valued at USD 1.57 billion in 2023, projected to reach USD 3.12 billion by 2031.

CAGR of 9% from 2024 to 2031.

Growing prevalence of Parkinson’s disease and epilepsy fueling demand.

Advancements such as MRI-compatible and rechargeable DBS systems are key drivers.

North America holds the largest share, with Asia-Pacific emerging as a growth hotspot.

Increased healthcare expenditure and favorable reimbursement policies supporting growth.

Future Scope:

The future of the Deep Brain Stimulation Devices Market appears promising, with continuous innovations such as closed-loop DBS systems and AI-integrated devices poised to redefine patient care. Researchers are exploring new applications of DBS beyond traditional neurological disorders, including psychiatric conditions and chronic pain management. Additionally, expanding healthcare infrastructure in emerging economies and favorable regulatory support are likely to open new avenues for market players.

Conclusion:

The Deep Brain Stimulation (DBS) Devices Market is on a robust growth trajectory, driven by technological advancements, rising neurological disease prevalence, and increasing patient awareness. With strong potential across developed and emerging regions, and ongoing research unlocking new therapeutic applications, the DBS devices market is set to witness sustained growth in the coming years.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Smart Healthcare Market

Optometry Equipment Market

Post Traumatic Stress Disorder Treatment Market

[jakeparalta90]

Implantable Neurostimulation Devices Market Development, Segment by Type, Region, Current Situation Market Size, Market Industry Market Forecast 2030

Summary

The Implantable Neurostimulation Devices Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Get Free Sample Report @ https://www.fusionmarketresearch.com/sample_request/(COVID-19-Version)-Global-Implantable-Neurostimulation-Devices-Market/4722

The report offers detailed coverage of Implantable Neurostimulation Devices industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Implantable Neurostimulation Devices by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Implantable Neurostimulation Devices market for 2016-2025.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]. At the same time, we classify Implantable Neurostimulation Devices according to the type, application by geography. More importantly, the report includes major countries market based on the type and application. Finally, the report provides detailed profile and data information analysis of leading Implantable Neurostimulation Devices company.

Leading players of Implantable Neurostimulation Devices including: Medtronic Boston Scientific St. Jude Medical (Abbott) LivaNova Nevro NeuroPace Beijing Pins Synapse Biomedical

Implantable Neurostimulation Devices Market split by Type, can be divided into: Spinal Cord Stimulation (SCS) Gastric Electric Stimulation (GES) Deep Brain Stimulation (DBS) Sacral Nerve Stimulation (SNS) Vagus Nerve Stimulation (VNS) Others

Implantable Neurostimulation Devices Market split by Application, can be divided into: Pain Management Parkinson’s Disease Urinary and Fecal Incontinence Epilepsy Gastroparesis Others

Implantable Neurostimulation Devices Market Report Scope

Report AttributeDetails

Base year of estimation2021

Historical data2017 – 2020

Forecast period2022 – 2030

Quantitative unitsRevenue in USD million/billion and CAGR from 2022 to 2030

Segmentation

By Type

By Application

By Region/Country

By Type Spinal Cord Stimulation (SCS), Gastric Electric Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS), Vagus Nerve Stimulation (VNS), Others

By Application Pain Management, Parkinson’s Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, Others

Report coverageRevenue forecast, company market share, competitive landscape, growth factors, and trends

Key companies profiledMedtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical

Regional scope

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Spain etc.)

Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

South America (Brazil, Argentina and Colombia etc.)

Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

Table of Contents

Part 1 Market Overview 1.1 Market Definition 1.2 Market Development 1.2.1 Current Situation 1.2.2 Aspects of COVID-19 Impact 1.3 By Type Table Type of Implantable Neurostimulation Devices Figure Global Implantable Neurostimulation Devices Market Share by Type in 2021 1.4 By Application Table Application of Implantable Neurostimulation Devices Figure Global Implantable Neurostimulation Devices Market Share by Application in 2021 1.5 By Region Figure Global Implantable Neurostimulation Devices Market Share by Region in 2021 Figure Asia Implantable Neurostimulation Devices Market Share by Region in 2021

Part 2 Key Companies 2.1 Medtronic 2.1.1 Company Profile Table Medtronic Overview List 2.1.2 Products & Services Overview 2.1.3 Sales Data List Table Implantable Neurostimulation Devices Business Operation of Medtronic (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 2.2 Boston Scientific 2.3 St. Jude Medical (Abbott) 2.4 LivaNova 2.5 Nevro 2.6 NeuroPace 2.7 Beijing Pins 2.8 Synapse Biomedical

Part 3 Global Market Status and Future Forecast 3.1 Global Market by Region Table Global Implantable Neurostimulation Devices Market by Region, 2017 – 2020 (Million USD) Figure Global Implantable Neurostimulation Devices Market Share by Region in 2021 (Million USD) Table Global Implantable Neurostimulation Devices Market by Region, 2017 – 2020 (Volume) Figure Global Implantable Neurostimulation Devices Market Share by Region in 2021 (Volume) Table Price List by Region, 2017 – 2020 3.2 Global Market by Company Table Global Implantable Neurostimulation Devices Market by Company, 2017 – 2020 (Million USD) Figure Global Implantable Neurostimulation Devices Market Share by Company in 2021 (Million USD) Table Global Implantable Neurostimulation Devices Market by Company, 2017 – 2020 (Volume) Figure Global Implantable Neurostimulation Devices Market Share by Company in 2021 (Volume) Table Price List by Company, 2017 – 2020 3.3 Global Market by Type Table Global Implantable Neurostimulation Devices Market by Type, 2017 – 2020 (Million USD) Figure Global Implantable Neurostimulation Devices Market Share by Type in 2021 (Million USD) Table Global Implantable Neurostimulation Devices Market by Type, 2017 – 2020 (Volume) Figure Global Implantable Neurostimulation Devices Market Share by Type in 2021 (Volume) Table Price List by Type, 2017 – 2020 3.4 Global Market by Application Table Global Implantable Neurostimulation Devices Market by Application, 2017 – 2020 (Million USD) Figure Global Implantable Neurostimulation Devices Market Share by Application in 2021 (Million USD) Table Global Implantable Neurostimulation Devices Market by Application, 2017 – 2020 (Volume) Figure Global Implantable Neurostimulation Devices Market Share by Application in 2021 (Volume) Table Price List by Application, 2017 – 2020 3.5 Global Market by Forecast Figure Global Implantable Neurostimulation Devices Market Forecast, 2022-2030 (Million USD) Figure Global Implantable Neurostimulation Devices Market Forecast, 2022-2030 (Volume)

Part 9 Market Features 9.1 Product Features 9.2 Price Features 9.3 Channel Features 9.4 Purchasing Features

Part 10 Investment Opportunity 10.1 Regional Investment Opportunity 10.2 Industry Investment Opportunity

PART 11 Coronavirus Impact 11.1 Impact on Industry Upstream 11.2 Impact on Industry Downstream 11.3 Impact on Industry Channels 11.4 Impact on Industry Competition 11.5 Impact on Industry Obtain Employment

Related Reports :          

Forced Convection Furnaces Market: https://www.newstrail.com/foodservice-disposables-distribution-systems-market/

Forged Rolls Market : https://www.newstrail.com/forged-rolls-market/                                                                                                                          

Forging Press Machine Market :    https://www.newstrail.com/forging-press-machine-market/                                                                                

[reportsandreports]

Neuromodulation Devices Market Report

Neuromodulation Devices Market Report analysis 2021-2027 presents a complete assessment of the market and comprises future trends, current growth factors, attentive opinions, facts, historical information, and forecasts. This Neuromodulation Devices Market is defined with its related details such as product types, business overview, sales, manufacturers, applications, and other specifications. It provides a systematic approach to the current and prospective scenario of the global regions. Detailed information of the Neuromodulation Devices Market Report growth rate, technological innovations, and key strategies implemented by the main leading industry players.

Request for FREE PDF Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=3518984

Top Company Profile Analysis in this Report- Medtronic plc, Abbott Laboratories, Boston Scientific Corp, LivaNova PLC, Nevro Corp, Nuvectra Corp,

Neuromodulation Devices (Neurology Devices) – Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Neurology Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Neuromodulation Devices market for the year 2020 and beyond. Due to the large prevalence of neurological conditions impacting the aging population, this huge geriatric population base is a large driver of the neuromodulation market.

Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS), Gastric Electric Stimulators (GES), Peripheral Nerve Stimulators (PNS) and Leads are tracked under this segment.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are – Currently marketed Neuromodulation Devices and evolving competitive landscape – – Insightful review of the key industry trends. – Annualized total Neuromodulation Devices market revenue by segment and market outlooks from 2015-2030. – Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights – – Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market. – SWOT analysis for Neuromodulation Devices market. – Competitive dynamics insights and trends provided for Neuromodulation Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape. – Country specific overview of the healthcare system. – Country specific reimbursement policies. – Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of this Report- This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for – – CMO executives who must have deep understanding of the Neuromodulation Devices marketplace to make strategic planning and investment decisions. – Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management. – Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Get FLAT 25% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=3518984

Reasons to Buy this Report- The model will enable you to – – Understand the impact of COVID-19 on Neuromodulation Devices market. – Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. – Develop business strategies by understanding the trends shaping and driving Neuromodulation Devices market. – Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neuromodulation Devices market in the future. – Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders. – Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. – Track device sales in the global and country-specific Neuromodulation Devices market from 2015-2030. – Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

[vivekbajaj-grs]

Neurostimulation Devices Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Neurostimulation Devices in global, including the following market information:

Global Neurostimulation Devices Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Neurostimulation Devices Market Sales, 2016-2021, 2022-2027, (K Units)

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-neurostimulation-devices-2021-2027-608

Global top five Neurostimulation Devices companies in 2020 (%)

The global Neurostimulation Devices market was valued at 6202.4 million in 2020 and is projected to reach US$ 9352.8 million by 2027, at a CAGR of 10.8% during the forecast period.

We surveyed the Neurostimulation Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurostimulation Devices Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Neurostimulation Devices Market Segment Percentages, By Type, 2020 (%)

Spinal Cord Stimulation (SCS)

Gastric Electric Stimulation (GES)

Deep Brain Stimulation (DBS)

Sacral Nerve Stimulation (SNS)

Vagus Nerve Stimulation (VNS)

Other

Global Neurostimulation Devices Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Neurostimulation Devices Market Segment Percentages, By Application, 2020 (%)

Pain Management

Parkinson?s Disease

Urinary and Fecal Incontinence

Epilepsy

Gastroparesis

Other

Global Neurostimulation Devices Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Neurostimulation Devices Market Segment Percentages, By Region and Country, 2020 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neurostimulation Devices revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Neurostimulation Devices revenues share in global market, 2020 (%)

Key companies Neurostimulation Devices sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Neurostimulation Devices sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Boston Scientific

Abbott

LivaNova

Nevro

NeuroPace

Beijing Pins

Synapse Biomedical

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-neurostimulation-devices-2021-2027-608

Table of content

1 Introduction to Research & Analysis Reports 1.1 Neurostimulation Devices Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Neurostimulation Devices Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Neurostimulation Devices Overall Market Size 2.1 Global Neurostimulation Devices Market Size: 2021 VS 2027 2.2 Global Neurostimulation Devices Revenue, Prospects & Forecasts: 2016-2027 2.3 Global Neurostimulation Devices Sales (Consumption): 2016-2027 3 Company Landscape 3.1 Top Neurostimulation Devices Players in Global Market 3.2 Top Global Neurostimulation Devices Companies Ranked by Revenue 3.3 Global Neurostimulation Devices Revenue by Companies 3.4 Global Neurostimulation Devices Sales by Companies 3.5 Global Neurostimulation Devices Price by Manufacturer (2016-2021) 3.6 Top 3 and Top 5 Neurostimulation Devices Companies in Global Market, by Revenue in 2020 3.7 Global Manufacturers Neurostimulation Devices Product Type 3.8 Tier 1, Tier 2 and Tier 3 Neurostimulation Devices Players in Global Market 3.8.1 List of Global Tier 1 Neurostimulation Devices Companies 3.8.2 List of Global Tier 2 and Tier 3 Neurostimulation Devices

CONTACT US: 276 5th Avenue, New York , NY 10001,United States International: (+1) 646 781 7170 / +91 8087042414 Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/

[techsciresearch]

Digital X-Ray Systems Market to Grow at a CAGR of 7.45% through 2026 | TechSci Research

Rising geriatric population is anticipated to drive the growth of global digital X-ray systems market in the forecast period.

According to TechSci Research report, “Global Digital X-Ray Systems Market By Technology (Direct Radiography v/s Computed Radiography), By Modality (Fixed v/s Mobile), By Application (General Radiography, Dental Applications, Mammography, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, the global digital X-ray systems market stood at USD11.74 billion in 2020 and is expected to grow at a CAGR of 7.45%, during the forecast period. This can be ascribed to the rising prevalence of diseases like orthopedic disorders, cancers/tumors, cardiovascular diseases (CVD), pneumonia and dental disorders. The increase in the number of these diseases and requirement for early detection is driving the growth of the global digital X-ray systems market in the upcoming five years.

Digital X-ray devices use digital X-ray sensors instead of films to capture images, provide immediate preview of the results, which improves time efficiency and capacity to digitally transfer images. Digital X-ray systems have various advantages over conventional X-ray systems like the quality of image, user friendliness, lesser image acquisition time, among others. Additionally, digital X-ray systems provide real time faster results which allows a greater number of patients to be screened in a given time, this in turn leads to lesser exposure to radiations. All these factors are expected to fuel the market growth.

However, digital X-ray systems are quite expensive therefore most of the small and medium-sized hospitals are unable to afford these systems. This in turn is expected to slow down the market growth through 2026. The high cost of digital X-ray systems also pushes end users towards refurbished systems, which directly cuts the overall sales of new and advanced systems. Moreover, the market suffers majorly due to the lack of reimbursement through health insurances. New investors may work on bringing the latest technologies at a more cost-efficient level. Additionally, stringent regulatory processes further restrict the market growth.

Browse over 161 market data Figures spread through 214 Pages and an in-depth TOC on "Global Digital X-ray Systems Market"

https://www.techsciresearch.com/report/digital-x-ray-systems-market/7387.html

The global digital X-ray systems market is segmented by technology, modality, application, end users, and regional distribution. Based on application, the market is further segmented into general radiography, dental applications, mammography, and others. The general radiography segment held the largest market share in 2020 of around 44.26%.  This can be ascribed to the growing prevalence of target diseases such as osteoporosis, cardiovascular diseases, tuberculosis, among others. Furthermore, growing geriatric population which is more susceptible to injuries & falls and different chronic diseases is further expected to drive the segmental growth over the next few years. An increasing number of COVID-19 cases has also increased the demand as digital X-ray systems play a key role in the diagnosis of COVID-19 and indicates the affected lung tissue in infected patients. X-ray systems have good applications in dental treatments as well.

Thus, the market is driving towards the anticipated growth based on these factors. In terms of end users, the market can be fragmented into hospitals & clinics, diagnostic centers and others. The hospitals & clinics segment dominated the market in 2020 and is expected to continue its dominance over the next few years because hospitals & clinics have proper infrastructural facilities, and they can easily make the investment required to have digital x-ray systems installed in their x-ray rooms. The diagnostic centers segment will witness significant growth over the next few years owing to the penetration of large diagnostic chains worldwide who are creating a huge demand for digital x-ray systems.

Some of the major competitors in the market are Siemens Healthineers AG, GE Healthcare Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Hologic Inc, Bracco Imaging S.p.A., Neusoft Medical Systems Co., Ltd., Agfa-Gevaert N.V., Samsung Medison Co., Ltd., Konica Minolta, Inc., Varex Imaging Corporation, KUB Technologies, Inc., MinXray, Inc., among others. These companies are adopting organic strategies such as mergers & acquisitions, product launches, among others in order to stay competitive in the market and are having an edge over the other players in the industry. For instance, In April 2021, Fujifilm Holdings Corporation completed the acquisition of Hitachi's diagnostic imaging business.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7387

Customers can also request for 10% free customization on this report.

“North America is expected to hold a dominant position in the global digital x-ray systems market over the forecast period, owing to the increasing number of patients suffering from arthritis. Additionally, the number of adults in the United States with doctor-diagnosed arthritis is projected to reach 78.4 million by 2040 which accounts for 25.9 percent of all adults in the United States as per the Arthritis Foundation Fact sheet, 2019. Along with the government support and FDI investments the market is anticipated to reach an impressive growth in next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Digital X-Ray Systems Market By Technology (Direct Radiography v/s Computed Radiography), By Modality (Fixed v/s Mobile), By Application (General Radiography, Dental Applications, Mammography, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global digital X-ray systems and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global digital x-ray systems.

Browse Related Reports:

Global MRI Market By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-To-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above)), By Type (Fixed, Mobile), By Architecture (Closed MRI Systems, Standard Bore MRI Systems, Wide-Bore MRI Systems, Open MRI Systems), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Vascular, Abdominal, Cardiac, Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/mri-market/5172.html

Global Deep Brain Stimulation (DBS) Devices Market By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic, Research Centers), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/deep-brain-stimulation-devices-market/5026.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

[techscimarketresearch]

Digital X-Ray Systems Market to Grow at a CAGR of 7.45% through 2026 | TechSci Research

Rising geriatric population is anticipated to drive the growth of global digital X-ray systems market in the forecast period.

According to TechSci Research report, “Global Digital X-Ray Systems Market By Technology (Direct Radiography v/s Computed Radiography), By Modality (Fixed v/s Mobile), By Application (General Radiography, Dental Applications, Mammography, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, the global digital X-ray systems market stood at USD11.74 billion in 2020 and is expected to grow at a CAGR of 7.45%, during the forecast period. This can be ascribed to the rising prevalence of diseases like orthopedic disorders, cancers/tumors, cardiovascular diseases (CVD), pneumonia and dental disorders. The increase in the number of these diseases and requirement for early detection is driving the growth of the global digital X-ray systems market in the upcoming five years.

Digital X-ray devices use digital X-ray sensors instead of films to capture images, provide immediate preview of the results, which improves time efficiency and capacity to digitally transfer images. Digital X-ray systems have various advantages over conventional X-ray systems like the quality of image, user friendliness, lesser image acquisition time, among others. Additionally, digital X-ray systems provide real time faster results which allows a greater number of patients to be screened in a given time, this in turn leads to lesser exposure to radiations. All these factors are expected to fuel the market growth.

However, digital X-ray systems are quite expensive therefore most of the small and medium-sized hospitals are unable to afford these systems. This in turn is expected to slow down the market growth through 2026. The high cost of digital X-ray systems also pushes end users towards refurbished systems, which directly cuts the overall sales of new and advanced systems. Moreover, the market suffers majorly due to the lack of reimbursement through health insurances. New investors may work on bringing the latest technologies at a more cost-efficient level. Additionally, stringent regulatory processes further restrict the market growth.

Browse over 161 market data Figures spread through 214 Pages and an in-depth TOC on "Global Digital X-ray Systems Market"

https://www.techsciresearch.com/report/digital-x-ray-systems-market/7387.html

The global digital X-ray systems market is segmented by technology, modality, application, end users, and regional distribution. Based on application, the market is further segmented into general radiography, dental applications, mammography, and others. The general radiography segment held the largest market share in 2020 of around 44.26%.  This can be ascribed to the growing prevalence of target diseases such as osteoporosis, cardiovascular diseases, tuberculosis, among others. Furthermore, growing geriatric population which is more susceptible to injuries & falls and different chronic diseases is further expected to drive the segmental growth over the next few years. An increasing number of COVID-19 cases has also increased the demand as digital X-ray systems play a key role in the diagnosis of COVID-19 and indicates the affected lung tissue in infected patients. X-ray systems have good applications in dental treatments as well.

Thus, the market is driving towards the anticipated growth based on these factors. In terms of end users, the market can be fragmented into hospitals & clinics, diagnostic centers and others. The hospitals & clinics segment dominated the market in 2020 and is expected to continue its dominance over the next few years because hospitals & clinics have proper infrastructural facilities, and they can easily make the investment required to have digital x-ray systems installed in their x-ray rooms. The diagnostic centers segment will witness significant growth over the next few years owing to the penetration of large diagnostic chains worldwide who are creating a huge demand for digital x-ray systems.

Some of the major competitors in the market are Siemens Healthineers AG, GE Healthcare Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Fujifilm Holdings Corporation, Shimadzu Corporation, Hologic Inc, Bracco Imaging S.p.A., Neusoft Medical Systems Co., Ltd., Agfa-Gevaert N.V., Samsung Medison Co., Ltd., Konica Minolta, Inc., Varex Imaging Corporation, KUB Technologies, Inc., MinXray, Inc., among others. These companies are adopting organic strategies such as mergers & acquisitions, product launches, among others in order to stay competitive in the market and are having an edge over the other players in the industry. For instance, In April 2021, Fujifilm Holdings Corporation completed the acquisition of Hitachi's diagnostic imaging business.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7387

Customers can also request for 10% free customization on this report.

“North America is expected to hold a dominant position in the global digital x-ray systems market over the forecast period, owing to the increasing number of patients suffering from arthritis. Additionally, the number of adults in the United States with doctor-diagnosed arthritis is projected to reach 78.4 million by 2040 which accounts for 25.9 percent of all adults in the United States as per the Arthritis Foundation Fact sheet, 2019. Along with the government support and FDI investments the market is anticipated to reach an impressive growth in next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global Digital X-Ray Systems Market By Technology (Direct Radiography v/s Computed Radiography), By Modality (Fixed v/s Mobile), By Application (General Radiography, Dental Applications, Mammography, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global digital X-ray systems and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global digital x-ray systems.

Browse Related Reports:

Global MRI Market By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-To-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above)), By Type (Fixed, Mobile), By Architecture (Closed MRI Systems, Standard Bore MRI Systems, Wide-Bore MRI Systems, Open MRI Systems), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Vascular, Abdominal, Cardiac, Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/mri-market/5172.html

Global Deep Brain Stimulation (DBS) Devices Market By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application (Obsessive Compulsive Disorder, Parkinson’s Disease, Essential Tremor, Epilepsy, Dystonia, Others), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Neurological Clinic, Research Centers), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/deep-brain-stimulation-devices-market/5026.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: sales@techsciresearch.com

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/